TeleMedC

TeleMedC | 848 followers on LinkedIn. Tomorrow’s solution, today. | A growing MedTech company, dedicated to preventing avoidable blindness and improving health outcomes by developing innovative Ai-powered products. 

Using cutting edge technology, we innovate hardware and software solutions and harness the power of AI to screen / detect / manage / monitor diseases on a global scale. 

Our exciting portfolio of products is optimising and revolutionizing eyecare.

Para Segaram

High Growth Companies and Technology Executive

Bryn Weaver

Scientist, TeleMedC

Di Xiao

Front End Developer I HTML I CSS I JavaScript I Python

Narayanankutty C

Diabetic Retinopathy is a leading cause of global blindness, yet early identification and timely treatment could prevent up to 95% of vision loss cases. RetinoScan is a trusted, comprehensive AI-powered solution that enables cost-efficient diagnostics across all levels of healthcare; from primary care to optometry settings and specialized eye care institutions. In Southeast Asia, where 90 million adults have been diagnosed with diabetes, and this number is projected to increase to 113 million by 2030 - scalable AI-driven diagnostic tools must be integrated to triage this escalating patient population. https://lnkd.in/eBGnV477 #diabetes #diabeticretinopathy #blindness #ai #eyecare #healthcare

Optometry Australia has released a timely position statement on use of AI. Good to see that they support responsible use of AI that can save eyes to improve lives. #retinalAI #SavingEyes #ImproveLives

Fabulous OATN Conference in Chennai! Our advanced yet affordable integrated fundus imaging and AI solutions are on display. The RetinoScan is regulatory approved and rolled out in Singapore, Germany and Australia. Dr. vinayak swarnkar, our country manager is ‘live’ onsite with the TeleMedC Indian team to spread the message of Saving Eyes to Improve Lives. #DiabeticRetinopathy #SaveSight #AI Join us on our mission today! Email us at: ask_us@telemedc.com

TeleMedC has just completed the final phase of our remote primary eye health project. Thanks to FISH - Foundation for Indigenous Sustainable Health and The University of Notre Dame Australia who helped in providing a culturally appropriate engagement through their health co-design principles. Special mention: Scott W. , Mark Anderson , Scott Martyn from FISH, fellow tech partners Rukshen Weerasooriya and Esther Oh in their unwavering support to improve First Nations health outcomes. #improvehealth #FirstNations

TeleMedC Singapore, Australia, Germany and India welcome Bryn Weaver as the President of TeleMedC Group Inc., USA. 🎉

TeleMedC features in Singapore’s Business Times as one of the companies using Germany as a gateway into European markets. We are “Saving Eyes to Improve Lives” everyday. Contact us if you would like to know more about our products and services. Email us: ask_us@telemedc.com https://lnkd.in/gR4AXmgh https://lnkd.in/gR4AXmgh #SavingEyes #Diabetes #Glaucoma #AMD #AI

TeleMedC technologies are working with esteemed partners to fulfil our mission of “Saving Eyes to Improve Lives” in Germany. https://lnkd.in/g2nK6JkM

TeleMedC is proud to be working with FISH - Foundation for Indigenous Sustainable Health to advance eye health in indigenous communities in Western Australia. We are saving eyes to improve lives. #diabetes #retinopathy #eyehealth #indigenoushealth

Thank you Mark Anderson and FISH - Foundation for Indigenous Sustainable Health for the great work in remote WA! TeleMedC is proud to be part of this national effort in saving eyes and improving lives for First Nations people. #ai #diabetes #retinopathy #eyehealth #primaryeyecare

TeleMedC is a proud recipient of the Australian Government’s CRC-P grant and partnering The Fred Hollows Foundation and University of Notre Dame Australia to develop eye care tools of the future. Our team is always looking for collaborators around the world. Give us a shout out if you’re passionate about preventing blindness. We are saving eyes to improve lives! #ai #savingeyes #cataracts

COM:TELEMEDC

TeleMedC

Analysis Not Available